SkinJect said it raised nearly $3 million for the patch it’s developing to treat skin cancers. The $2.5 million equity round, revealed yesterday in a regulatory filing, involved 13 unnamed investors, Pittsburgh-based SkinJect said. The company is working on a thumb-sized device that features a dissolvable microneedle array to deliver drugs directly to top layers of […]
